Partnerships for Advancing Development of Diagnostics for Infectious Diseases
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- September 24, 2026
- Closes
- See announcement
- Program funding
- $10,000,000
- Expected awards
- 10
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.855
- Category
- Health
Program funding history
Awards made under Assistance Listing 93.855 across FY2025–FY2027, from public federal spending records.
- FY2025 obligated
- $4.2B
- FY2026 obligated
- $4B
- FY2027 (to date) obligated
- $0
- Awards in window
- 12,807
Top recipients: The Johns Hopkins University, Regents of the University of California, San Francisco, the, Fred Hutchinson Cancer Center, Emory University, Duke University
Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →
Synopsis
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting partnerships between academic (or small business) investigators and one or more industrial partner(s) for translational development of a diagnostic test that has demonstrated proof-of-concept. Novel diagnostics are needed to implement treatment strategies, evaluate vaccines and identify infectious disease outbreaks, but too often, early diagnostic breakthroughs are not being translated into successful commercial products. Investigators often develop promising diagnostics but then face barriers when navigating the process towards commercialization. The goal is to align investigators with experienced industry partners early in the development process, to enable early de-risking and ensure that the end-product will be fit for purpose. A science advisory board together with NIAID oversight will help maintain the focus of projects. Annual meetings and workshops will foster collaborations and knowledge exchange with biotech/industry developers, and other investigators in the early diagnostic space. This partnership concept aligns with NIH’s mission to support the translation of the most promising diagnostic technologies to better treat and prevent infectious diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Who can apply
- City or township governments
- State governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Native American tribal governments (Federally recognized)
- Small businesses
- For profit organizations other than small businesses
- Special district governments
- County governments
- Independent school districts
- Public housing authorities/Indian housing authorities
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.
New to federal funding? How to read an announcement · Who can apply · How grants work
Tell me when this program posts again
One email the morning after this program opens for applications — under this number or a new one — and one more about a week before it closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.
Similar grants
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
- Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases
- Translational Centers Using Microphysiologic Systems for Infectious Diseases
- Centers for Research on Neglected Infectious Diseases
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
See pricing